000597.SZ · 东北制药
China A-shares · RS rating 75 · As of 2026-10-14
| Price | 4.79 CNY |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 75 / 76 / 69 / 53 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 37 / 28 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -33.9% |
| Distance from 52-week high | +18.3% |
| Market cap (USD) | $1.0B |